Past, present, and future of Japanese encephalitis - PubMed (original) (raw)
Past, present, and future of Japanese encephalitis
Tobias E Erlanger et al. Emerg Infect Dis. 2009 Jan.
Abstract
Japanese encephalitis (JE), a vector-borne viral disease, is endemic to large parts of Asia and the Pacific. An estimated 3 billion people are at risk, and JE has recently spread to new territories. Vaccination programs, increased living standards, and mechanization of agriculture are key factors in the decline in the incidence of this disease in Japan and South Korea. However, transmission of JE is likely to increase in Bangladesh, Cambodia, Indonesia, Laos, Myanmar, North Korea, and Pakistan because of population growth, intensified rice farming, pig rearing, and the lack of vaccination programs and surveillance. On a global scale, however, the incidence of JE may decline as a result of large-scale vaccination programs implemented in China and India.
Figures
Figure 1
Contextual determinants and transmission of Japanese encephalitis.
Figure 2
Disability-adjusted life years (DALYs) per 100,000 persons in Japanese encephalitis–endemic countries. Number in parentheses indicate estimated number of deaths in 2002 according to the World Health Organization (20). NA, not available.
Comment in
- Past, present, and future of Japanese encephalitis.
Hills SL, Phillips DC. Hills SL, et al. Emerg Infect Dis. 2009 Aug;15(8):1333. doi: 10.3201/eid1508.090149. Emerg Infect Dis. 2009. PMID: 19751614 Free PMC article. No abstract available.
Similar articles
- The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
Moore SM. Moore SM. PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009385. doi: 10.1371/journal.pntd.0009385. eCollection 2021 Oct. PLoS Negl Trop Dis. 2021. PMID: 34644296 Free PMC article. - Japanese encephalitis: the virus and vaccines.
Yun SI, Lee YM. Yun SI, et al. Hum Vaccin Immunother. 2014;10(2):263-79. doi: 10.4161/hv.26902. Epub 2013 Oct 25. Hum Vaccin Immunother. 2014. PMID: 24161909 Free PMC article. Review. - Risk assessment for Japanese encephalitis vaccination.
Turtle L, Driver C. Turtle L, et al. Hum Vaccin Immunother. 2018 Jan 2;14(1):213-217. doi: 10.1080/21645515.2017.1380756. Epub 2017 Dec 21. Hum Vaccin Immunother. 2018. PMID: 29244615 Free PMC article. Review. - Japanese encephalitis vaccine: need of the hour in endemic states of India.
Verma R. Verma R. Hum Vaccin Immunother. 2012 Apr;8(4):491-3. doi: 10.4161/hv.18925. Epub 2012 Feb 28. Hum Vaccin Immunother. 2012. PMID: 22370517 Review. - Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC). Fischer M, et al. MMWR Recomm Rep. 2010 Mar 12;59(RR-1):1-27. MMWR Recomm Rep. 2010. PMID: 20224546
Cited by
- Japanese Encephalitis Virus Surveillance in U.S. Army Installations in the Republic of Korea from 2021 to 2023.
Lado P, Crispell GP, Chong ST, Kim MS, Esparza AN, Zielinski E, Iwami A, Williams KP, Eads JJ, Jimbo K, Mitzel DN, Cohnstaedt LW, Richardson JB, Kugelman JR, Stoops CA. Lado P, et al. Pathogens. 2024 Aug 20;13(8):705. doi: 10.3390/pathogens13080705. Pathogens. 2024. PMID: 39204305 Free PMC article. - Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh.
Duque MP, Naser AM, Dos Santos GR, O'Driscoll M, Paul KK, Rahman M, Alam MS, Al-Amin HM, Rahman MZ, Hossain ME, Paul RC, Luby SP, Cauchemez S, Vanhomwegen J, Gurley ES, Salje H. Duque MP, et al. Sci Adv. 2024 Aug 9;10(32):eadp1657. doi: 10.1126/sciadv.adp1657. Epub 2024 Aug 9. Sci Adv. 2024. PMID: 39121225 Free PMC article. - Generation of rescued Japanese encephalitis virus genotype 1 from infectious full-size clone using reverse genetics.
Kim S, Kim MS, Nowakowska A, Choi H, Bang HW, Kim YB, Lee HJ. Kim S, et al. Heliyon. 2024 Jun 17;10(13):e33142. doi: 10.1016/j.heliyon.2024.e33142. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040327 Free PMC article. - Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine.
Park JY, Lee HM, Jun SH, Kamitani W, Kim O, Shin HJ. Park JY, et al. Vaccines (Basel). 2024 May 30;12(6):597. doi: 10.3390/vaccines12060597. Vaccines (Basel). 2024. PMID: 38932326 Free PMC article. - Inflammatory & Apoptotic Factor Fluctuations Associated with Japanese Encephalitis Virus Infection in Transgenic IFNAR1-/- Mice.
Lin XH, Chowdhury D, Seo SH. Lin XH, et al. Curr Microbiol. 2024 Jun 23;81(8):239. doi: 10.1007/s00284-024-03759-w. Curr Microbiol. 2024. PMID: 38910205
References
- United Nations. The United Nations urbanization prospects: the 2005 revision. POP/DB/WUP/Rev.2005/1/F1. New York: United Nations; 2005.
- World Health Organization. World health report. (for years 2000–2004) [cited 2008 Oct 14]. Available from http://www.who.int/whr/en
- Vaughn DW, Hoke CH Jr. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev. 1992;14:197–221. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous